Release Date: 14/01/22 19:39 Summary: Change of Director's Interest Notice x5 Price Sensitive: No Download Document 456.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%